Boosted by strong performances in the healthcare sector, the UK’s FTSE 100 hit a record high on Wednesday, closing up 0.85% at 10402.34 points. Leading the charge was pharmaceutical giant GSK, which climbed 6.9% after releasing positive fourth-quarter results, setting the stage for a new growth phase focusing on R&D.
Swiss insurer Zurich’s takeover proposal saw Beazley shares surge by the same margin, influencing the nonlife insurance index upward by 4.7%. Meanwhile, European software stocks continue to face pressure as investors shift toward value-based options, shaking confidence in tech markets.
Despite growth in Britain’s services sector, price increases pose challenges ahead of the Bank of England’s policy meeting. The BoE is anticipated to maintain its current borrowing rate, awaiting further inflation clarity. With mixed performances in other sectors, market volatility remains a central concern.